Cargando…
Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer
BACKGROUND: To assess 18-fluorodeoxyglucose (FDG) bowel uptake in patients with differentiated thyroid cancer (DTC) treated with sorafenib. FINDINGS: Visual (5-point scale) and high maximum standard uptake value (SUVmax) semi-quantitative analyses were conducted in 63 positron emission tomography (P...
Autores principales: | Ciappuccini, Renaud, Trzepla, Géraldine, Heutte, Natacha, Sevin, Emmanuel, Galais, Marie Pierre, Bardet, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426461/ https://www.ncbi.nlm.nih.gov/pubmed/22564710 http://dx.doi.org/10.1186/2191-219X-2-18 |
Ejemplares similares
-
Thyroid (18)F-fluorocholine uptake in patients with chronic autoimmune thyroiditis
por: Ciappuccini, Renaud, et al.
Publicado: (2022) -
Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome
por: Ciappuccini, Renaud, et al.
Publicado: (2020) -
Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck (18)FDG PET/CT imaging in differentiated thyroid cancer
por: Ciappuccini, Renaud, et al.
Publicado: (2018) -
Incremental Value of a Dedicated Head and Neck Acquisition during (18)F-FDG PET/CT in Patients with Differentiated Thyroid Cancer
por: Ciappuccini, Renaud, et al.
Publicado: (2016) -
HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological (18)F-FDG anal uptake
por: Aide, Nicolas, et al.
Publicado: (2020)